Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada

BACKGROUND: In Canada, discussion about changing from cytology to human papillomavirus (hpv) dna testing for primary screening in cervical cancer is ongoing. However, the Canadian Task Force on Preventive Health Care has not yet made a recommendation, concluding that the evidence is insufficient. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Popadiuk, C., Gauvreau, C.L., Bhavsar, M., Nadeau, C., Asakawa, K., Flanagan, W.M., Wolfson, M.C., Coldman, A.J., Memon, S., Fitzgerald, N., Lacombe, J., Miller, A.B.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780581/
https://ncbi.nlm.nih.gov/pubmed/26985148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.2991
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados